What are Value Stocks?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.
The following stocks are considered to be notable value stocks in the healthcare sector:
- Onconova Therapeutics ONTX - P/E: 0.85
- Genesis Healthcare GEN - P/E: 1.5
- Coherus BioSciences CHRS - P/E: 7.13
- Seneca Biopharma SNCA - P/E: 9.82
- Five Star Senior Living FVE - P/E: 3.65
Onconova Therapeutics has reported Q2 earnings per share at -0.04, which has decreased by 33.33% compared to Q1, which was -0.03. Onconova Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Genesis Healthcare has reported Q2 earnings per share at -0.2, which has decreased by 171.43% compared to Q1, which was 0.28. Genesis Healthcare does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Coherus BioSciences has reported Q2 earnings per share at 0.81, which has increased by 68.75% compared to Q1, which was 0.48. Coherus BioSciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Seneca Biopharma has reported Q2 earnings per share at -0.15, which has increased by 37.5% compared to Q1, which was -0.24. Seneca Biopharma does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Most recently, Five Star Senior Living reported earnings per share at 0.1, whereas in Q1 earnings per share sat at -0.55. Five Star Senior Living does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.